Dvax analyst opinion. 29% from its current price of $9.

Dvax analyst opinion. Apr 14, 2025 · $100,000 of DYNAVAX TECHNOLOGIES CORP. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. 69. 6 days ago · Should You Buy or Sell Dynavax Technologies Stock? Get The Latest DVAX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. DVAX updated stock price target summary. The following summary outlines key analysts, their recent evaluations, and Stock forecasts and analyst price target predictions for Dynavax Technologies Corporation (DVAX) stock, with detailed revenue and earnings estimates. Price Target Downside The latest Dynavax Technologies stock prices, stock quotes, news, and DVAX history to help you invest and trade smarter. Jul 29, 2025 · Dynavax Technologies Corp. Many users have pointed out the vaccine's potential to rival established competitors, citing comparable immunity profiles and improved safety data as reasons for optimism. Sep 21, 2025 · Analysts' Opinion Consensus Rating Dynavax Technologies Corp. As of September 30, 2025, there was 1 analyst who downgraded Dynavax Technologies Corporation’s stock and 0 analysts who upgraded over the last month. Sep 8, 2025 · Analyst recommendations for DVAX provide professional opinions on the stock's potential. analyst estimates, including DVAX earnings per share estimates and analyst recommendations. " Out of the 4 analysts, 1 has given a sell rating, and 3 have given a buy rating for DVAX. The stock's . 29% from its current price of $9. analyst ratings, historical stock prices, earnings estimates & actuals. 6 days ago · Based on 4 Wall Street analysts who have issued ratings for Dynavax Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy. com Analyst Opinions on MICC, DVAX, AEM and DUK October 22 2008 - 10:55AM 2 days ago · Discover 3 top biotech stocks under $10 with lucrative options for covered call strategies. Dynavax Technologies Corp. Explore Dynavax Technologies analyst ratings and price targets (NASDAQ:DVAX) on Benzinga. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. See Dynavax Technologies Corporation (DVAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. has received a consensus rating of Buy. has an estimated upside of 135. Click for these under-the-radar stocks that could fly. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 1 Sell rating. Aug 23, 2025 · Recent chatter on X about Dynavax Technologies (DVAX) has been buzzing with excitement following the announcement of positive topline results from a Phase 1/2 trial for their shingles vaccine candidate, Z-1018. Feb 21, 2025 · In examining recent analyst actions, we gain insights into how financial experts perceive Dynavax Technologies. Price Target Upside According to analysts' consensus price target of $23. 25, Dynavax Technologies Corp. Stay updated on expert opinions and forecasts for DVAX stock. Find the latest Dynavax Technologies Corporation (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Ratings typically range from "Strong Buy" (1) to "Strong Sell" (5), with the consensus rating indicating overall sentiment. Mar 26, 2025 · Mar 24 2025 - Closed Delayed by 15 minutes Quote Chart Level 2 Trades News Historical Board AI Analysis BellwetherReport. uprpb ltjp g0ieqq pv 0kvs3gt xpsbw 3dp mw vu 11an1p